Art

J-GLOBAL ID：201502209534998798   Reference number：15A1263777

Efficacy of pirfenidone and disease severity of idiopathic pulmonary fibrosis: Extended analysis of phase III trial in Japan

特発性肺線維症のピルフェニドン効果と疾患感受性:日本における臨床第3相試験の拡張解析

Author (13)： TAGUCHI Yoshio (Dep. of Respiratory Medicine, Tenri Hospital, Tenri, Nara 632-8552, JPN) ,  EBINA Masahito (Dep. of Respiratory Medicine, Tohoku Pharmaceutical Univ., JPN) ,  HASHIMOTO Seishu (Dep. of Respiratory Medicine, Tenri Hospital, Tenri, Nara 632-8552, JPN) ,  OGURA Takashi (Dep. of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, JPN) ,  AZUMA Arata (Dep. of Pulmonary Medicine and Oncology, Nippon Medical School, JPN) ,  TANIGUCHI Hiroyuki (Dep. of Respiratory Medicine and Allergy, Tosei General Hospital, JPN) ,  KONDOH Yasuhiro (Dep. of Respiratory Medicine and Allergy, Tosei General Hospital, JPN) ,  SUGA Moritaka (Center for Preventive Medicine, Saiseikai Kumamoto Hospital, JPN) ,  TAKAHASHI Hiroki (Third Dep. of Internal Medicine, Sapporo Medical Univ. Hospital, JPN) ,  NAKATA Koichiro (Dep. of Respiratory Medicine, Nakata Clinic, JPN) ,  SUGIYAMA Yukihiko (Div. of Pulmonary Medicine, Dep. of Medicine, Jichi Medical Univ., JPN) ,  KUDOH Shoji (Japan Anti-Tuberculosis Assoc., JPN) ,  NUKIWA Toshihiro (Japan Anti-Tuberculosis Assoc., JPN)
Material： Respiratory Investigation  (Respir Investig)
Volume： 53  Issue： 6  Page： 279-287  Publication year： Nov. 2015 
JST Material Number： W2316A  ISSN： 2212-5345  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Thesaurus term： *Pulmonary Fibrosis ,...
Semi thesaurus term： *Idiopathic Pulmonary Fibrosis ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A1263777&from=J-GLOBAL&jstjournalNo=W2316A") }}

JST classification (3)： Drug therapy(=pharmacotherapy)for respiratory system diseases  (GI05020J) ,  Clinical application of drugs acting on respiration and respiratory system  (GW08020U) ,  Epidemiology  (GB03000E)

Substance index (1)： Pirfenidone

Reference (43)：

• An Official ATS/ERS/JRS/ALAT Statement. Idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
• King Jr TE, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011;378:1949-61.
• Raghu G, Johnson WC, Lockhart D, et al. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study. Am J Respir Crit Care Med 1999;159:1061-9.
• Nagai S, Hamada K, Shigematsu M, et al. Open-label compassionate use one year-treatment with pirfenidone to patients with chronic pulmonary fibrosis. Intern Med 2002;41:1118-23.
• Iwasawa T, Ogura T, Sakai F, et al. CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis. Eur J Radiol 2014;83:32-8.

Terms in the title (8)： 特発性肺線維症 ,  ピルフェニドン ,  疾患感受性 ,  日本 ,  臨床 ,  第3相試験 ,  拡張 ,  解析